MedTrace Logo

Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific Low Backache

NCT07467070 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-03-12

No results posted yet for this study

Summary

The aim of this clinical trial is to study the effects of Pilates intervention versus conventional therapy on postural correction, core strength and flexibility in young individuals with complaint of non-specific low backache. The main question is whether the Pilates has better improvement as compared to the conventional therapy on postural correction, core strength and flexibility moreover to compare the effectiveness of two intervention. Participants of age 18-25 years and with complaint of non-specific low backache will be recruited. 50 participants will be enrolled. Participants will perform Pilates and conventional therapy for 3 times per week for six weeks. Participants will be randomly allocated to two groups and assessor blinding will be done to take baseline assessment. Assessor blinding is done to minimize biasness. Pre and Post assessments will be taken by the assessor. SPSS will be used for the analysis of the data.

Conditions

  • Low Back Pain
  • Postural Control
  • Core Strength
  • Flexibility
  • Pilates
  • Non-specific Low Back Pain

Interventions

BEHAVIORAL

Pilates

Participants will perform supervised mat-based Pilates exercise program designed to improve posture, core strength and flexibility. This intervention will be only applied to experimental group. Pilates is a mind body exercise system that emphasize on controlled breathing pattern with proper alignment of the body. Intervention will be applied for six weeks.

BEHAVIORAL

conventional therapy

Participants will receive structured and supervised conventional therapy aiming at posture, core strength and flexibility. It consists of standardized therapeutic exercises commonly used in clinical practice and clinical guidelines. Conventional Therapy will be applied for six weeks to both the groups.

Sponsors & Collaborators

  • University of Health Sciences Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-03
Primary Completion
2026-04-09
Completion
2026-04-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07467070 on ClinicalTrials.gov